Literature DB >> 16287753

Confirmation of a role for the 389R>G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure.

A J Sandilands, J Parameshwar, S Large, M J Brown, K M O'Shaughnessy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16287753      PMCID： PMC1769224          DOI： 10.1136/hrt.2004.047282

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer.

Authors:  D B Northridge; S Grant; I Ford; J Christie; J McLenachan; D Connelly; J McMurray; S Ray; E Henderson; H J Dargie
Journal:  Br Heart J       Date:  1990-11

2.  Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.

Authors:  Lynne E Wagoner; Laura L Craft; Paul Zengel; Nancy McGuire; Deborah A Rathz; Gerald W Dorn; Stephen B Liggett
Journal:  Am Heart J       Date:  2002-11       Impact factor: 4.749

3.  Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes.

Authors:  A Martinsson; K Lindvall; A Melcher; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

4.  Functional responses of human beta1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphisms.

Authors:  Alastair Sandilands; Giles Yeo; Morris J Brown; Kevin M O'Shaughnessy
Journal:  Pharmacogenetics       Date:  2004-06

5.  Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium.

Authors:  A J Sandilands; K M O'Shaughnessy; M J Brown
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739
  5 in total
  8 in total

Review 1.  Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Mol Pharmacol       Date:  2009-06-02       Impact factor: 4.436

Review 2.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 3.  Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

Review 4.  The genomic architecture of sporadic heart failure.

Authors:  Gerald W Dorn
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

5.  Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT.

Authors:  Amber E Johnson; Karen Hanley-Yanez; Clyde W Yancy; Anne L Taylor; Arthur M Feldman; Dennis M McNamara
Journal:  J Card Fail       Date:  2019-04-09       Impact factor: 5.712

Review 6.  Clinical considerations of heritable factors in common heart failure.

Authors:  Thomas P Cappola; Gerald W Dorn
Journal:  Circ Cardiovasc Genet       Date:  2011-12

Review 7.  Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.

Authors:  Elham Kayvanpour; Hugo A Katus; Benjamin Meder
Journal:  Curr Heart Fail Rep       Date:  2015-10

8.  In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.

Authors:  Kirsten Leineweber; Petra Bogedain; Christina Wolf; Sören Wagner; Melanie Weber; Heinz-Günther Jakob; Gerd Heusch; Thomas Philipp; Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-01       Impact factor: 3.195
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.